Transcarent
Facts
- HQ
- United States
- Sectors
- Health benefits, Healthcare, Healthtech
- Founded
- 2020
- Stage
- Series D
Sana Biotechnology Appoints Brian Piper as CFO; Aptevo CEO Marvin White to Step Down in April; Violett Names Scott Kushino CEO
Brian Piper was appointed CFO and executive vice president at Sana Biotechnology, while Marvin White will step down as Aptevo CEO in April, succeeded by COO Jeff Lamothe. Additionally, Scott Kushino became CEO of Seattle startup Violett, and several other leadership changes occurred across Seattle and New York tech companies.
Concur Co-Founders Back SCALA.AI to Revolutionize Customer Experience with AI Across Healthcare, Finance, and Retail
Seattle startup SCALA.AI, backed by Concur co-founders Raj Singh and Mike Hilton, is developing AI-driven customer experience solutions for sectors like healthcare, finance, and retail. Led by CEO Ardie Sameti, SCALA.AI aims to offer advanced, vertically tailored AI platforms beyond basic automation.
98point6 Raises $30.7M to Expand Software Licensing After $100M Sale to Transcarent
Seattle-based digital health company 98point6 raised $30.7 million in mixed debt and option financing to support its transition into a software licensor following its sale of a virtual care and primary care business to Transcarent. The new funding led by L Catterton, Activant Capital, and Transcarent will scale its software platform and develop AI innovations.
Seattle's 98point6 Sells Virtual Care Platform and Primary Care Business to Transcarent for $100M
Seattle healthcare startup 98point6 is selling its virtual care platform and primary care business to San Francisco-based Transcarent for $100 million in cash and equity, with the transaction expected to close by March 31. Post-sale, 98point6 will focus exclusively on software licensing as 98point6 Technologies, while about half of its workforce, including clinical staff, will move to Transcarent.
